Postmenopausal hormone replacement therapy and cardiovascular disease: the value of transdermal estradiol and micronized progesterone

By Mueck A. O.  

Climacteric, Vol. 15, Iss. 1, 2012-04 ,pp. : 11-17

Informa Healthcare

Access to resources Recommend Favorite

Vaginal rings delivering progesterone and estradiol may be a new method of hormone replacement therapy

By Maruo T.   Mishell D.R.   Ben-Chetrit A.   Hochner-Celnikier D.   Hamada A.L.   Nash H.A.  

Fertility and Sterility, Vol. 78, Iss. 5, 2002-11 ,pp. : 1010-1016

Elsevier

Access to resources Recommend Favorite

HRT optimization, using transdermal estradiol plus micronized progesterone, a safer HRT

By L’Hermite M.  

Climacteric, Vol. 16, Iss. 1, 2013-08 ,pp. : 44-53

Informa Healthcare

Access to resources Recommend Favorite

Comparison of changes in biochemical markers of bone turnover after 6 months of hormone replacement therapy with either transdermal 17 -estradiol or equine conjugated estrogen plus nomegestrol acetate

By Collette J.   Viethel P.   Dethor M.   Chevallier T.   Micheletti M.C.   Foidart J.M.   Reginster J.Y.  

Gynecology Obstetrique & Fertilite, Vol. 31, Iss. 5, 2003-05 ,pp. : 434-441

Elsevier

Access to resources Recommend Favorite

Effects of transdermal hormone replacement therapy on levels of soluble P- and E-selectin in postmenopausal healthy women

By Farzati A.   Esposito K.   Colacurci N.   Fornaro F.   Chiantera V.   Farzati B.  

Fertility and Sterility, Vol. 77, Iss. 3, 2002-03 ,pp. : 476-480

Elsevier

Access to resources Recommend Favorite